Skip to Content

BBJ Biotech in Boston: Leading the Way in Life Sciences

Halloran is excited to participate in BBJ’s Biotech in Boston on August 1st. This event will feature dynamic panel discussions where attendees can hear from industry leaders and change-makers about this crucial sector of our economy.

We anticipate insightful discussions on topics such as access to capital and M&A activity, leadership strategies for new and veteran CEOs in the current environment, and insights from biotech executives and real estate experts on the state of the biotech real estate market.

Consulting Magazine WebCast – Balancing Growth Objectives with Operational Efficiency: Unleashing Partner Productivity

Halloran will be participating in Consulting Magazine’s Webcast on Thursday, July 11, 2024 at 11 AM EST with Brittany Sipos, Chief Operations Officer serving as a Subject Matter Expert (SME) on the panel discussing “Balancing Growth Objectives with Operational Efficiency: Unleashing Partner Productivity.”

Register here!

Operational leaders in professional services firms are increasingly valuing agility, flexibility, and efficiency to drive innovation and growth. These qualities are now seen as critical for boosting creativity, productivity, and expertise, rather than just cutting costs.

Join us to explore how firms are striking a balance between strategic growth and operational efficiency. We’ll examine innovative strategies that elevate the performance of professionals dedicated to generating billable work, from harnessing the right technology to investing in the right support partners. 

The discussion will highlight insights from a recent C-level survey investigating how professional services firms are optimizing operational efficiency through technology advancements, such as Gen AI and machine learning, and how they are partnering with service providers to stay focused on their core strategies. We will look at what factors are influencing budgeting and spending decisions for firms over the next 12 months. We’ll uncover the levers firms are using to enhance fee-earner productivity, create operational efficiencies, and secure competitive advantages.

BIO Florida Conference 

We are looking forward to Florida’s Leading Life Sciences Conference – The BioFlorida Conference this November in Orlando, Florida!

Be sure to visit our experts at Halloran’s tabletop in the exhibit hall.

BioFlorida is the voice of Florida’s life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians.

Live Webinar – Key Strategies for Development Stage Biotechs: Developing an Organization and the Talent Within

Join Halloran on Tuesday, June 25th for a live webinar discussing Key Strategies for Development Stage Biotechs: Developing an Organization and the Talent Within. In partnership with The Leadership Edge we’ll explore the essential strategies for cultivating both organizational excellence and talent development within the development stages a biotech or biopharma company advances through in the development of their product or asset. Register here!

In this session, experts from The Leadership Edge, Halloran Consulting Group, and Inozyme Pharma will delve into the challenges and opportunities faced by life science companies today, offering practical insights and actionable advice on building robust organizational structures, fostering a culture of quality, and nurturing talent to drive sustainable growth.

Whether you’re a seasoned life sciences executive or an up-and-coming leader, this webinar promises invaluable guidance for navigating the dynamic landscape of biopharmaceutical and biotechnology development.

Live Webinar – Halloran’s Inspection Readiness Methodology: Failure to Plan is a Plan to Fail

Join us for a live webinar on Tuesday, June 11th to discuss Halloran‘s Inspection Readiness Methodology: Failure to Plan is a Plan to Fail. Health Authority inspection of a clinical trial can occur at any time during a product’s lifecycle. Adequate preparation is essential to better position an organization for a successful inspection with the goal of market approval. Register here!

Too often, we observe sponsors tackling inspection preparedness right before a key milestone, such as Biologics License Application (BLA) or New Drug Application (NDA) submissions. However, this approach often results in stress, overwhelmed teams, and avoidable inspection findings, potentially delaying development milestones.

Being inspection ready is more than just a checklist. Rather, sponsors must adopt an inspection readiness mindset earlyn on through establishing an ongoing efficient process to maintain compliance and guarantee preparedness. If this resonates, you also may be wondering, ‘what does this mindset look like?’

Join our webinar and learn:

Biocom CEO Summit

Tania Zieja, Halloran President, is excited to attend the Biocom CEO Summit in San Diego, CA, on November 7th. She looks forward to gaining valuable insights, engaging with peers from biotech, pharma, and medtech companies, and staying at the forefront of the ever-evolving life sciences landscape.

Boston Happy Hour

Join Halloran for Networking and Drinks!

Enjoy refreshments and light bites on us. Let’s get to know our Boston life science community.

San Francisco Happy Hour

Join Halloran for Networking and Drinks!

Enjoy refreshments and light bites on us. Let’s get to know our Bay Area life science community.

Tufts Center for the Study of Drug Development – Research Symposium

Halloran is excited to join the Tufts Center for the Study of Drug Development for an esteemed research symposium titled “New Medicines at the Crossroads: Drug Development and the Forces Necessitating Transformation.” This event pays tribute to Professor Kenneth I Kaitin, Former Director of the Tufts Center for the Study of Drug Development.

We anticipate insightful discussions, including a keynote address from Ken, covering critical and strategic issues impacting the global drug development enterprise and insights from the Food and Drug Administration on the newly established Office of Clinical Trial Innovation.

CBSA Annual All Member Meeting

Halloran will attend CBSA’s annual All Member Meeting, providing a chance to hear updates from CBSA leaders and board members on Colorado’s life sciences landscape and member accomplishments.

Don’t miss the chance to meet our experts at our tabletop booth.

The event will showcase a panel of ecosystem leaders discussing the Colorado Hub for Health Impact, a new nationwide economic development initiative showcasing Colorado as a hub for life sciences innovation in the United States.